Last €36.55 EUR
Change Today -0.258 / -0.70%
Volume 0.0
PJR On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 3:01 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

piper jaffray cos (PJR) Snapshot

Open
€36.87
Previous Close
€36.80
Day High
€36.87
Day Low
€36.55
52 Week High
07/7/14 - €38.83
52 Week Low
07/22/13 - €23.11
Market Cap
594.5M
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
16.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PIPER JAFFRAY COS (PJR)

piper jaffray cos (PJR) Details

Piper Jaffray Companies provides investment banking, institutional brokerage, asset management, and related financial services in the United States and Europe. The company's Capital Markets segment provides investment banking and institutional sales, trading, and research services for various equity and fixed income products. This segment raises capital through equity financings; provides advisory services, primarily relating to mergers and acquisitions for its corporate clients; underwrites debt issuances; and offers financial advisory and interest rate risk management services. Its public finance investment banking capabilities focus on state and local governments, cultural and social service non-profit entities, and the healthcare, education, senior living, and hospitality sectors, as well as on business and financial services, clean technology and renewables, consumer, healthcare, industrial growth, technology, media, and telecommunications industries. This segment also offers equity and fixed income advisory and trade execution services for institutional investors, and government and non-profit entities; and is involved in trading activities for customer facilitation and strategic trading purposes, as well as has equity sales and trading relationships with institutional investors. In addition, this segment is engaged in merchant banking activities, which comprise equity or debt investments in late stage private companies, and investments in private equity and venture capital funds, and other firm investments, as well as has alternative asset management funds, which invest in municipal securities and merchant banking. Its Asset Management segment provides traditional asset management services with product offerings in equity securities and master limited partnerships to institutions and individuals through separately managed accounts and open-end and closed-end funds. Piper Jaffray Companies was founded in 1895 and is headquartered in Minneapolis, Minnesota.

1,026 Employees
Last Reported Date: 02/28/14
Founded in 1895

piper jaffray cos (PJR) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $650.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $500.0K
Head of Fixed Income Services, Managing Direc...
Total Annual Compensation: $425.0K
Co-Head of Global Investment Banking & Capita...
Total Annual Compensation: $425.0K
Global Co-Head of Investment Banking & Capita...
Total Annual Compensation: $425.0K
Compensation as of Fiscal Year 2013.

piper jaffray cos (PJR) Key Developments

Meredian Inc. Engages Piper Jaffray to Explore Possibilities

Meredian Inc. announced its plans to explore financing opportunities. The company has engaged Piper Jaffray in connection with its efforts.

Piper Jaffray Companies Andy Clayton as a Principal in its Investment Banking Group

Piper Jaffray Companies announced that Andy Clayton has joined the firm as a principal in its investment banking group. He will be based in the firm's Hong Kong office. Clayton brings substantial cross-border M&A, equity and debt advisory experience to the firm. He was previously a senior vice president with Jefferies' Hong Kong investment banking team, and prior to that, served as an investment banking director in UBS' Hong Kong office.

Piper Jaffray Companies Appoints Chris Collins as Principal in its Biotechnology Investment Banking Group

Piper Jaffray announced that Chris Collins has joined the firm as a principal in its biotechnology investment banking group. His experience includes more than 14 years in financial services including 12 years focused on the biotechnology industry. He will be based in the firm's San Francisco office. Collins joins the firm from Citigroup. Collins joins the firm from Citigroup, where he was a director in the healthcare investment banking group focused on biotechnology companies. He previously worked at Credit Suisse, CPC Capital Management, Frazier Healthcare Ventures and Morgan Stanley.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PJR:GR €36.55 EUR -0.258

PJR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cowen Group Inc $4.06 USD -0.04
Greenhill & Co Inc $43.78 USD -0.94
RCS Capital Corp $20.96 USD -0.37
SWS Group Inc $7.14 USD -0.14
Westamerica Bancorporation $50.65 USD -1.01
View Industry Companies
 

Industry Analysis

PJR

Industry Average

Valuation PJR Industry Range
Price/Earnings 14.5x
Price/Sales 1.3x
Price/Book 1.0x
Price/Cash Flow 13.5x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PIPER JAFFRAY COS, please visit www.piperjaffray.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.